Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Nematode Infection Controls Obesity and Modulates Body Weight and Metabolism

By BiotechDaily International staff writers
Posted on 09 May 2013
Print article
In an interesting combination of low and high technology approaches to the control and treatment of obesity, a recent study suggested that infection with parasitic nematodes (roundworms) could suppress the chronic inflammation associated with obesity and modulate body weight and metabolism.

Obesity is associated with a chronic low-grade inflammation characterized by increased levels of proinflammatory cytokines that are implicated in metabolic dysfunction. Nematode infection, which elevates host immune Th2-cells and related type two cytokines, has been used in ancient medicine and is currently under clinical investigation for treatment for diseases associated with the relevant cytokines, including inflammatory bowel disease, multiple sclerosis, and allergies

Investigators at the University of Maryland School of Medicine (Baltimore, USA) examined the possibility of using nematode infection to treat obesity. They worked with several strains of mice that were fed normal or high-fat diets.

They reported in the March 18, 2013, online edition of the journal Infection and Immunity that normal size mice infected with the nematode Nippostrongyrus brasiliensis fed a high-fat diet gained 15% percent less weight than control animals that were not infected. Mice that were already obese when infected lost roughly 13% of their body weight within 10 days. Infected animals were found to have decreased fasting blood glucose levels and reduced incidence of fatty liver disease.

"The levels of insulin and leptin also dropped, indicating that the mice restored their sensitivities to both hormones," said senior author Dr. Aiping Zhao, associate professor of radiation oncology at the University of Maryland School of Medicine. "Leptin moderates appetite. As with too much insulin, too high a level of leptin results in insensitivity, thus contributing to obesity and metabolic syndrome."

Related Links:

University of Maryland School of Medicine



Print article

Channels

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.